131 related articles for article (PubMed ID: 11216561)
1. Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.
Elwell RJ; Bailie GR; Manley HJ
Perit Dial Int; 2000; 20(6):694-8. PubMed ID: 11216561
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients.
Elwell RJ; Manley HJ; Frye RF; Bailie GR
Int J Artif Organs; 2005 Aug; 28(8):808-16. PubMed ID: 16211531
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
4. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
[TBL] [Abstract][Full Text] [Related]
8. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
[TBL] [Abstract][Full Text] [Related]
9. Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Diaz-Buxo JA; Crawford TL; Bailie GR
Perit Dial Int; 2001; 21 Suppl 3():S197-201. PubMed ID: 11887820
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L
Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ceftazidime in CAPD-related peritonitis.
Booranalertpaisarn V; Eiam-Ong S; Wittayalertpanya S; Kanjanabutr T; Na Ayudhya DP
Perit Dial Int; 2003; 23(6):574-9. PubMed ID: 14703199
[TBL] [Abstract][Full Text] [Related]
14. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.
Vonesh EF; Story KO; O'Neill WT
Perit Dial Int; 1999; 19(6):556-71. PubMed ID: 10641777
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Low CL; Gopalakrishna K; Lye WC
J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
[TBL] [Abstract][Full Text] [Related]
16. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis.
Kim K; Hwang YH; Ro H; Oh YK; Kim MG; Yu KS; Shin KH; Jang IJ; Shin SG; Ahn C; Oh KH
Antimicrob Agents Chemother; 2011 Jun; 55(6):2523-7. PubMed ID: 21402833
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
Grabe DW; Bailie GR; Eisele G; Frye RF
Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
[TBL] [Abstract][Full Text] [Related]
19. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
Tzamaloukas AH; Malhotra D; Murata GH
ASAIO J; 1998; 44(6):828-34. PubMed ID: 9831093
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of peritoneal dialysis-associated peritonitis with cefazolin and ceftazidime in children.
Rusthoven E; Monnens LA; Schröder CH
Perit Dial Int; 2001; 21(4):386-9. PubMed ID: 11587402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]